SEC Form 4 · accession 0001645470-19-000008
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Jan 30, 2019
Accepted (ET)
Feb 5, 2019 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2019 | P | 5,000 | $0.0262 | A | 21,057,623 | D | |
| Common Stock | Jan 30, 2019 | P | 5,000 | $0.0259 | A | 21,062,623 | D | |
| Common Stock | Jan 30, 2019 | P | 5,000 | $0.0254 | A | 21,067,623 | D | |
| Common Stock | Jan 30, 2019 | P | 5,000 | $0.0254 | A | 21,072,623 | D | |
| Common Stock | Jan 30, 2019 | P | 5,000 | $0.026 | A | 21,077,623 | D | |
| Common Stock | Jan 30, 2019 | P | 5,000 | $0.026 | A | 21,082,623 | D | |
| Common Stock | Jan 31, 2019 | P | 5,000 | $0.0257 | A | 21,087,623 | D | |
| Common Stock | Jan 31, 2019 | P | 5,000 | $0.0259 | A | 21,087,623 | D | |
| Common Stock | Jan 31, 2019 | P | 5,000 | $0.0259 | A | 21,092,623 | D | |
| Common Stock | Jan 31, 2019 | P | 1,000 | $0.0263 | A | 21,093,623 | D |
Table II — derivative securities
No Table II lines on this filing.